Stem-Cell Based 3D Organoids; Application in Microbial Pathogenesis and Advances

A special issue of Microorganisms (ISSN 2076-2607). This special issue belongs to the section "Medical Microbiology".

Deadline for manuscript submissions: closed (30 April 2024) | Viewed by 130

Special Issue Editor


E-Mail Website
Guest Editor
Department of Biomedical & Nutritional Sciences, Zuckerberg College of Health Sciences, University of Massachusetts-Lowell, Lowell, MA, USA
Interests: viral hepatitis; new emerging pathogen; acute hepatitis of unknown etiology; pathogenesis; animal model
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Three-dimensional (3D) organoids are considered a preclinical model for studying human disease. These organoids are developed from stem cells that can expand in vitro and they physiologically mimic the internal organs. Recent approaches enable the development of organoids from different organs such as the colon, intestine, kidney, pancreas, endometrium, etc.  These organoids can be used for studying microbial pathogenesis and identification of the pathways associated with the disease pathogenesis. Application of gene editing technologies such as CRISPR/Cas9 in the organoid model helps to identify human disease and develop a cancer model in vitro.  Besides, 3D organoids and 2D enteriod-derived monolayers (EDMs) can be used for screening drugs, anti-cancer therapies, nutritional supplements, and other potential therapeutic candidates that could be beneficial for personalized medicine.

The Special Issue entitled "Stem-Cell Based 3D Organoids; Application in Microbial Pathogenesis and Advances" aims to present recent research on mysteries of use of stem-cell based model for studying host-pathogen interaction and testing potential therapeutic candidates. 

Dr. Ibrahim M. Sayed
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • 3D organoids and enteriod derived monolayer
  • stem cells and primary epithelial cells
  • gene editing and CRISPR-Cas systems
  • in vitro model system
  • host-pathogen interactions
  • evaluation theraputic candidates

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop